Introduction
Leading diagnostic services provider signs Memorandum of Understanding with multispeciality clinic for pathology lab operations, sample pickup services and referral radiology support under agreed terms.
Also Read: Gujarat Themis Biosyn to acquire Sanofi anti-TB and anti-infective portfolio
Share price movement of Clinitech
On April 24, 2026, Clinitech Laboratory Ltd opened at ₹41.00, down 2.38% from its previous close of ₹42.00. The stock reached a high of ₹41.00 and a low of ₹40.00. By 16:00 PM, it traded at ₹40.00, a 4.76% decrease, with a market cap of ₹9.13 crore.
Clinitech signs MOU with clinic
Clinitech Laboratory Limited signed a Memorandum of Understanding dated April 25, 2026 with MD Plus Multispeciality Clinic for operating a pathology laboratory and related diagnostic services.
The agreement also includes handling pickup points for pathology samples and providing full referral radiology services under defined terms and conditions between both parties as disclosed.
Stock performance of Clinitech for period of 1 week, 6 months, and 1 year
Clinitech Laboratory Ltd delivered a 1-week return of -12.1%, a 6-month return of -5.93%, and a 1-year return of -11.4%.
Also Read: Tata Power forms new subsidiary TP Urja Limited for new energy initiatives, here is key details
Shareholding pattern of Clinitech
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
| Promoter | 64% | 62% | 62% |
| FII | 0.30% | 0.30% | 0.30% |
| DII | 0.00% | 0.00% | 0.00% |
| Public | 35.50% | 37.30% | 38.10% |
About Clinitech
Clinitech Laboratory Limited (BSE: 544220) provides NABL accredited healthcare services including pathology testing, diagnostic centres, scan centres, X-ray centres and ECG clinics across locations.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Clinitech Laboratory Ltd share price rising today?
A: Clinitech Laboratory Ltd share price movement relates to MOU signed with MD Plus Clinic for pathology and referral radiology services expansion.
Q: What is Clinitech Laboratory Ltd’s main business focus?
A: Clinitech Laboratory Ltd provides NABL accredited healthcare services including pathology labs, diagnostic centres, scan centres, X-ray centres and ECG clinics.
Q: What are the 52-week high and low of Clinitech Laboratory Ltd stock?
A: Clinitech Laboratory Ltd stock has a 52 week high of ₹57.00 and a 52 week low of ₹28.55.
